[EN] METHODS FOR THE IDENTIFICATION, EVALUATION AND TREATMENT OF PATIENTS HAVING MULTIPLE MYELOMA<br/>[FR] MÉTHODES POUR L'IDENTIFICATION, L'ÉVALUATION ET LE TRAITEMENT DE PATIENTS ATTEINTS D'UN MYÉLOME MULTIPLE
申请人:MILLENNIUM PHARM INC
公开号:WO2017079572A1
公开(公告)日:2017-05-11
The present disclosure relates to methods for the treatment of multiple myeloma in patients who have one or more cytogenetic alterations. In particular, the disclosure provides methods for treatment of multiple myeloma in patients who have one or more cytogenetic alternations by administering to a patient a treatment regimen comprising a proteasome inhibitor or a pharmaceutically acceptable salt, stereoisomeric or tautomeric form thereof if said patient is identified as a likely responder to the treatment regimen by assessing the presence of said cytogenetic alterations.